FRRS1L
Basic information
Region (hg38): 9:109130293-109167249
Previous symbols: [ "C9orf4" ]
Links
Phenotypes
GenCC
Source:
- developmental and epileptic encephalopathy, 37 (Moderate), mode of inheritance: AR
- autosomal recessive non-syndromic intellectual disability (Supportive), mode of inheritance: AR
- developmental and epileptic encephalopathy, 37 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Developmental and epileptic encephalopathy 37 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 27236917; 27239025 |
ClinVar
This is a list of variants' phenotypes submitted to
- Developmental and epileptic encephalopathy, 37 (16 variants)
- Chorea;Progressive encephalopathy;Seizure (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FRRS1L gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 69 | 71 | ||||
missense | 158 | 162 | ||||
nonsense | 10 | |||||
start loss | 0 | |||||
frameshift | 12 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
splice region | 2 | 8 | 1 | 11 | ||
non coding | 33 | 42 | 17 | 94 | ||
Total | 16 | 12 | 194 | 113 | 18 |
Highest pathogenic variant AF is 0.0000197
Variants in FRRS1L
This is a list of pathogenic ClinVar variants found in the FRRS1L region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-109137174-A-G | Benign (Jul 26, 2018) | |||
9-109137458-G-A | Developmental and epileptic encephalopathy, 37 | Likely benign (Nov 02, 2023) | ||
9-109137464-T-A | Developmental and epileptic encephalopathy, 37 | Likely benign (Jan 24, 2024) | ||
9-109137468-A-T | Uncertain significance (Mar 01, 2018) | |||
9-109137475-G-A | Developmental and epileptic encephalopathy, 37 | Likely benign (Jan 05, 2024) | ||
9-109137475-G-C | Developmental and epileptic encephalopathy, 37 | Uncertain significance (Aug 12, 2022) | ||
9-109137476-G-C | Developmental and epileptic encephalopathy, 37 | Uncertain significance (Mar 18, 2022) | ||
9-109137477-T-C | Developmental and epileptic encephalopathy, 37 | Uncertain significance (Aug 16, 2022) | ||
9-109137485-C-T | Developmental and epileptic encephalopathy, 37 | Likely benign (Sep 13, 2022) | ||
9-109137486-A-C | Developmental and epileptic encephalopathy, 37 | Uncertain significance (May 24, 2020) | ||
9-109137507-C-T | Developmental and epileptic encephalopathy, 37 • Inborn genetic diseases | Uncertain significance (Dec 03, 2021) | ||
9-109137515-A-T | Developmental and epileptic encephalopathy, 37 | Likely benign (Apr 03, 2021) | ||
9-109137517-A-T | Uncertain significance (Jan 28, 2020) | |||
9-109137519-G-A | Developmental and epileptic encephalopathy, 37 | Uncertain significance (Aug 31, 2021) | ||
9-109137524-G-A | Developmental and epileptic encephalopathy, 37 | Likely benign (Nov 01, 2023) | ||
9-109137528-T-G | Inborn genetic diseases | Uncertain significance (Sep 20, 2023) | ||
9-109137529-G-A | Developmental and epileptic encephalopathy, 37 • Progressive encephalopathy;Chorea;Seizure | Pathogenic (Mar 14, 2024) | ||
9-109137531-T-C | Developmental and epileptic encephalopathy, 37 | Uncertain significance (Feb 25, 2022) | ||
9-109137535-C-T | Developmental and epileptic encephalopathy, 37 | Uncertain significance (Aug 09, 2022) | ||
9-109137543-G-A | Developmental and epileptic encephalopathy, 37 | Uncertain significance (Jul 19, 2022) | ||
9-109137544-GC-TT | Developmental and epileptic encephalopathy, 37 | Uncertain significance (Dec 20, 2021) | ||
9-109137552-A-C | Developmental and epileptic encephalopathy, 37 | Uncertain significance (Jul 06, 2022) | ||
9-109137553-T-C | Developmental and epileptic encephalopathy, 37 | Uncertain significance (Oct 20, 2018) | ||
9-109137555-T-A | Inborn genetic diseases | Uncertain significance (Mar 29, 2023) | ||
9-109137563-C-G | Developmental and epileptic encephalopathy, 37 | Uncertain significance (Mar 22, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FRRS1L | protein_coding | protein_coding | ENST00000561981 | 5 | 36999 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00146 | 0.884 | 125735 | 0 | 10 | 125745 | 0.0000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.581 | 121 | 140 | 0.862 | 0.00000748 | 2147 |
Missense in Polyphen | 26 | 37.172 | 0.69944 | 407 | ||
Synonymous | -0.0283 | 51 | 50.7 | 1.00 | 0.00000269 | 734 |
Loss of Function | 1.37 | 6 | 10.9 | 0.551 | 5.20e-7 | 158 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000615 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000592 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000616 | 0.0000615 |
Middle Eastern | 0.0000592 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Important modulator of glutamate signaling pathway. {ECO:0000269|PubMed:27236917}.;
Recessive Scores
- pRec
- 0.120
Haploinsufficiency Scores
- pHI
- 0.203
- hipred
- N
- hipred_score
- 0.410
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Frrs1l
- Phenotype
- homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- regulation of postsynaptic membrane neurotransmitter receptor levels;regulation of glutamate receptor signaling pathway
- Cellular component
- cellular_component;plasma membrane;integral component of membrane;cell junction;synapse
- Molecular function
- molecular_function